Budesonide enhances repeated gene transfer and expression in the lung with adenoviral vectors

American Journal of Respiratory and Critical Care Medicine

Volumn 164, Issue 5, 2001, Pages 866-872

  Kolb, Martin ^b   Inman, Mark ^b   Margetts, Peter J ^b   Galt, Tom ^b   Gauldie, Jack ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

Adenoviral gene transfer; Budesonide; Gene expression

Indexed keywords

BUDESONIDE; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER; IMMUNE RESPONSE; LUNG; LUNG LAVAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE;

EID: 0035447558     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.164.5.2008066     Document Type: Article

References (26)

1. Status of gene therapy for cystic fibrosis lung disease
2. Gene therapy for lung inflammatory diseases: Not so far away?
3. Gene therapy
4. Gene vectors for cytokine expression in vivo
5. Structure and genetic organization of adenovirus vectors
6. Effect of inhaled glucocorticoid on the cellular profile and cytokine levels in induced sputum from asthmatic patients
7. Inhaled steroids in asthma
8. Construction of recombinant human type 5 adenoviruses expressing rodent IL-6 genes: An approach to investigate in vivo cytokine function
9. An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3
10. GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice
11. Murine dendritic cells transduced with an adenoviral vector expressing a defined tumor antigen can overcome anti-adenovirus neutralizing immunity and induce effective tumor regression
12. Transient expression of genes transferred in vivo into heart using first-generation adenoviral vectors: Role of the immune response
13. Immediate inflammatory responses to adenovirus-mediated gene transfer in rat salivary glands
14. Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses
15. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
16. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice
17. Circumventing the immune response to adenovirus-mediated gene therapy
18. Suppression of inflammation by dexamethasone prolongs adenoviral vector-mediated transgene expression in the facial nucleus of the rat
19. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector
20. Suppression of the immune response to an adenovirus vector and enhancement of intratumoral transgene expression by low-dose etoposide
21. Immunomodulation with FK506 around the time of intravenous re-administration of an adenoviral vector facilitates gene transfer into primed rat liver
22. Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung
23. Anti-T cell receptor antibody prolongs transgene expression and reduces lung inflammation after adenovirus-mediated gene transfer
24. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure
25. Readministration of adenovirus vector in nonhuman primate lungs by blockade of CD40-CD40 ligand interactions